Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Graft-versus-host disease (GVHD) is a principal cause of morbidity following allogeneic hematopoietic cell transplantation (HCT). Standard therapy for GVHD, high-dose steroids, results in complete responses (CRs) in 35% of patients. Because tumor necrosis factor-α (TNFα) is an important effector of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Levine, John E., Paczesny, Sophie, Mineishi, Shin, Braun, Thomas, Choi, Sung W., Hutchinson, Raymond J., Jones, Dawn, Khaled, Yasser, Kitko, Carrie L., Bickley, Daniel, Krijanovski, Oleg, Reddy, Pavan, Yanik, Gregory, Ferrara, James L. M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361693/
https://ncbi.nlm.nih.gov/pubmed/18042798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-112987
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars